Nebraska Innovation Campus
The Combine
Accessibility Remediation
If you are unable to use this item in its current form due to accessibility barriers, you may request remediation through our remediation request form.
Date of this Version
4-29-2021
Document Type
News Article
Citation
The Combine (Nebraska Innovation Campus) April 29, 2021.
Also available at: https://innovate.unl.edu/news/thyreos-completes-seed-funding-invest-nebraska-strategic-angel-investors and https://www.nebraskacombine.com/post/thyreos-completes-seed-funding-from-invest-nebraska-and-strategic-angel-investors
Abstract
First paragraph:
Thyreos (https://www.thyreosvaccines.com/), a vaccine company that is developing a novel vaccine platform that protects against a range of herpesviruses, has announced a $750,000 investment round led by Invest Nebraska with participation from other local angel investors in the animal health and veterinary space.
Included in
Business Commons, Infectious Disease Commons, Medical Immunology Commons, Other Public Health Commons, Preventive Medicine Commons, Virus Diseases Commons
Comments
Copyright 2021, Nebraska Innovation Campus. Used by permission.